Literature DB >> 12014477

The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.

S Anil1, A N B Ellepola, L P Samaranayake.   

Abstract

Oral candidiasis is the most common opportunistic infection in individuals infected with the human immunodeficiency virus. Though Candida albicans is the major aetiological agent, non-albicans species such Candida tropicalis are now emerging as important agents of such infection. The Candida cell surface hydrophobicity (CSH) is considered a critical factor contributing to its colonization potential and virulence. It is also known that brief exposure to sub-cidal concentrations of antifungal agents is a likely scenario in the oral environment where the administered drugs are diluted continuously due to the flushing action of saliva. Hence the objective of the present study was to compare the CSH of 10 isolates each of C. albicans and C. tropicalis from HIV-infected individuals following brief exposure (1 hour) of isolates to sub-therapeutic concentrations of nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine. The CSH was assessed by a previously described biphasic aqueous-hydrocarbon assay. The mean percentage reduction of CSH of C. albicans following brief exposure to nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine was 27.33 (p < 0.001), 21.34 (p < 0.05), 11.74 (p > 0.05), 18.4 (p > 0.05) and 14.64 (p > 0.05) respectively. The mean percentage reduction of CSH of C. tropicalis following brief exposure to nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine was 33.81 (p < 0.01), 28.88 (p < 0.01), 12.6 (p > 0.05), 21.53 (p > 0.05) and 17.68 (p > 0.05) respectively. A significant interspecies variation in CSH was observed for nystatin and amphoterecin B. Overall the results reveal that the CSH of C. albicans is affected to a significantly lesser degree compared with C. tropicalis when exposed to the antifungals. These data further illustrate another mode of action of antifungals on Candida leading to a reduction in the CSH and thereby the yeast adherence to host tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014477     DOI: 10.1023/a:1014932302518

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  24 in total

Review 1.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.

Authors:  H Egusa; A N Ellepola; H Nikawa; T Hamada; L P Samaranayake
Journal:  J Oral Pathol Med       Date:  2000-05       Impact factor: 4.253

3.  Evaluation of the modified API 20C system for identification of clinically important yeasts.

Authors:  W J Buesching; K Kurek; G D Roberts
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

Review 4.  Candida and oral candidosis: a review.

Authors:  C Scully; M el-Kabir; L P Samaranayake
Journal:  Crit Rev Oral Biol Med       Date:  1994

Review 5.  Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.

Authors:  W G Powderly; J E Gallant; M A Ghannoum; K H Mayer; E E Navarro; J R Perfect
Journal:  AIDS Res Hum Retroviruses       Date:  1999-12-10       Impact factor: 2.205

6.  The in vitro post-antifungal effect of nystatin on Candida species of oral origin.

Authors:  A N Ellepola; L P Samaranayake
Journal:  J Oral Pathol Med       Date:  1999-03       Impact factor: 4.253

7.  The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells.

Authors:  A N Ellepola; L P Samaranayake
Journal:  Arch Oral Biol       Date:  1998-11       Impact factor: 2.633

8.  Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues.

Authors:  K C Hazen; D L Brawner; M H Riesselman; M A Jutila; J E Cutler
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 9.  Impact of the changing epidemiology of fungal infections in the 1990s.

Authors:  M Pfaller; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

10.  Hydrophobic interaction in Candida albicans and Candida tropicalis adherence to various denture base resin materials.

Authors:  S Minagi; Y Miyake; K Inagaki; H Tsuru; H Suginaka
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  4 in total

1.  Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.

Authors:  Sukumaran Anil; Mohamed Hashem; Sajith Vellappally; Shankargouda Patil; H M H N Bandara; L P Samaranayake
Journal:  Mycopathologia       Date:  2014-08-21       Impact factor: 2.574

2.  Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.

Authors:  C J Seneviratne; L J Jin; Y H Samaranayake; L P Samaranayake
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

3.  Assessment of Antifungal Activity of Bakuchiol on Oral-Associated Candida spp.

Authors:  Mohd-Al-Faisal Nordin; Fathilah Abdul Razak; Wan Harun Himratul-Aznita
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-08       Impact factor: 2.629

4.  Changes in the cell surface hydrophobicity of oral Candida albicans from smokers, diabetics, asthmatics, and healthy individuals following limited exposure to chlorhexidine gluconate.

Authors:  Arjuna N B Ellepola; Bobby K Joseph; Z U Khan
Journal:  Med Princ Pract       Date:  2012-12-18       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.